Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
47.9M
-
Number of holders
-
169
-
Total 13F shares, excl. options
-
51M
-
Shares change
-
-268K
-
Total reported value, excl. options
-
$1.48B
-
Value change
-
-$32M
-
Number of buys
-
101
-
Number of sells
-
-64
-
Price
-
$28.99
Significant Holders of HAEMONETICS CORP - Common Stock (HAE) as of Q2 2016
188 filings reported holding HAE - HAEMONETICS CORP - Common Stock as of Q2 2016.
HAEMONETICS CORP - Common Stock (HAE) has 169 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 51M shares
.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (5.37M shares), VANGUARD GROUP INC (4.04M shares), BlackRock Fund Advisors (3.33M shares), WELLS FARGO & COMPANY/MN (2.67M shares), WELLINGTON MANAGEMENT GROUP LLP (2.52M shares), FULLER & THALER ASSET MANAGEMENT, INC. (2.13M shares), Black Creek Investment Management Inc. (2.04M shares), Neuberger Berman Group LLC (1.92M shares), DIMENSIONAL FUND ADVISORS LP (1.8M shares), and Van Berkom & Associates Inc. (1.53M shares).
This table shows the top 169 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.